| | | | | |
OTLK Outlook Therapeutics, Inc. Common Stock | €1,2634 | -0,35% | €222,14M | €4,51M | |
SIDU Sidus Space, Inc. Class A Common Stock | €2,3344 | +0,76% | €222,14M | €10,40M | |
GLO Clough Global Opportunities Fund | €5,3682 | +0,00% | €222,09M | €125,94K | |
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares | €3,6677 | +0,12% | €221,97M | €221,05K | |
FULC Fulcrum Therapeutics, Inc. Common Stock | €3,3661 | +0,26% | €221,37M | €1,49M | |
IKT Inhibikase Therapeutics, Inc. Common Stock | €1,7399 | +0,00% | €220,48M | €593,64K | |
FCT First Trust Senior Floating Rate Income Fund II | €8,3933 | +0,00% | €220,35M | €37,78K | |
ATGL Alpha Technology Group Limited Class A Ordinary Shares | €10,0282 | +1,82% | €219,99M | €499,22 | |
ACRE Ares Commercial Real Estate Corporation | €3,9606 | +0,22% | €218,76M | €274,03K | |
SCII SC II Acquisition Corp. Class A ordinary share | €8,7780 | +0,10% | €217,89M | €5,08K | |
USAU U.S. Gold Corp. Common Stock | €14,4260 | +0,06% | €217,41M | €269,24K | |
RCS PIMCO STRATEGIC INCOME FUND, INC. | €4,7789 | -0,80% | €217,16M | €83,23K | |
EVGO EVgo Inc. Class A Common Stock | €1,6437 | +0,54% | €217,05M | €2,34M | |
QADR QDRO Acquisition Corp. Class A Ordinary Shares | €8,6556 | -0,60% | €216,93M | €49,36K | |
MKLY McKinley Acquisition Corporation Class A Ordinary Shares | €8,9056 | +0,06% | €216,88M | €2,23K | |
